References
- DalbyRNEicherJZierenbergBDevelopment of Respimat(®) Soft Mist™ inhaler and its clinical utility in respiratory disordersMed Devices20114145155
- SchürmannWSchmidtmannSMoroniPMasseyDQidanMRespimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfactionTreat Respir Med200541536115725050
- ChrystynHSmallMMilliganGHigginsVGilEGEstruchJImpact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPDRespir Med2014108235836524209768
- HochrainerDHölzHKreherCScaffidiLSpallekMWachtelHComparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalersJ Aerosol Med200518327328216181002
- NewmanSPSteedKPReaderSJHooperGZierenbergBEfficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizerJ Pharm Sci19968599609648877887
- CaillaudDLe MerreCMartinatYAguilaniuBPaviaDA dose-ranging study of tiotropium delivered via Respimat Soft Mist inhaler or HandiHaler in COPD patientsInt J Chron Obstruct Pulmon Dis20072455956518268929
- International Organization for StandardizationISO 20072: 2009 – aerosol drug delivery device design verification – requirements and test methods Available from: https://www.iso.org/standard/41989.htmlAccessed May 25, 2018
- ZieglerJWachtelHComparison of cascade impaction and laser diffraction for particle size distribution measurementsJ Aerosol Med200518331132416181006
- WachtelHZieglerJImproved assessment of inhaler device performance using laser diffractionRespir Drug Deliv20022379382
- NinaneVVandevoordeJCataldoDNew developments in inhaler devices within pharmaceutical companies: a systematic review of the impact on clinical outcomes and patient preferencesRespir Med2015109111430143826439177
- PriceDHarrowBSmallMPikeJHigginsVEstablishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physiciansWorld Allergy Organ J2015812626417397
- GálffyGMezeiGNémethGInhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPDDrugs R D201313321522224043456
- MäkeläMJBackerVHedegaardMLarssonKAdherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespir Med2013107101481149023643487
- ValipourATammMKociánováJBayer ZubekVMedvedchikovAHaaksma HerczeghMImprovement of self-reported physical functioning with tiotropium/olodaterol in Central and Eastern European COPD patientsEur Respir J201852Suppl 62PA912
- HodderRPriceDPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerInt J Chron Obstruct Pulmon Dis2009438139019888356
- Dal NegroRWPoveroMAcceptability and preference of three inhalation devices assessed by the handling questionnaire in asthma and COPD patientsMultidiscip Respir Med2016111726865979
- HaenselMBambachTWachtelHA comparison of product carbon footprints of Respimat® versus pressurized metered dose inhalersRespir Drug Deliv20182321324
- HaenselMBambachTWachtelHReduced environmental impact of a reusable soft mist inhalerEur Respir J201852Supplement 62PA1021